Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage

• Main Authors: Wen Jiang (Author), Zherui Zhang (Author), Yuhe Zhu (Author), Ben Chen (Author), Chunying Gu (Author), Zhiyan Liu (Author), Xukai Zhang (Author), Hualong Xiong (Author), Yanan Zhang (Author), Bin Zheng (Author), Rongjuan Wang (Author), Shasha Jiao (Author), An Wang (Author), Tianying Zhang (Author), Jinchao Zhang (Author), Shuang Wang (Author), Bo Zhang (Author), Gang Li (Author), Xun Gui (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, several variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged and have consistently replaced the previous dominant variant. Therapeutics against variants of SARS-CoV-2 are urgently needed. Ide...